DOI: 10.1097/01.COT.0000289881.74390.8f

,  

Issn Print: 0276-2234

Publication Date: 2002/11/01


Print

New Medicines In Development for Cancers that Disproportionately Affect African Americans

    loading  Checking for direct PDF access through Ovid

Excerpt

This table is adapted and excerpted from the latest Pharmaceutical Research and Manufacturers of America survey of New Medicines in Development for Major Diseases Affecting African Americans. As of the time of the report in September, there were 249 medicines in development for such diseases.
In addition to the selected cancers noted in the following chart, these diseases are diabetes, eye disorders/glaucoma, heart disease/hypertension, HIV infection/AIDS, kidney disorders, obesity, respiratory/lung disorders, sickle cell disease, and stroke.
African Americans have disproportionately high rates of multiple myeloma and cancers of the esophagus, cervix, uterus, larynx, stomach, mouth, pancreas, and prostate. The medicines in the pipeline target cancers of the cervix, colon/rectum, esophagus, larynx, liver, lung, pancreas, prostate, stomach, and uterus, as well as multiple myeloma and non-Hodgkin's lymphoma.
All of the medicines listed are either in clinical trials or awaiting FDA approval. Shown for each item are the name of the product, the company/organization involved, the cancer indication, and the development status as of the time of the report.
    loading  Loading Related Articles